GT Biopharma, Inc. (GTBP) stock
GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$3.18−0.35 (-10.04%)
Close on Nov 17, 2026Market cap $143.45MP/E –Yield –
GT Biopharma operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2015 it was -33063.0%, against -3927.9% the year before. The highest annual figure on record is -215.5% in fiscal 2013.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | -33063.0% | −29135.1 |
| FY2014 | Dec 31, 2014 | -3927.9% | −3712.4 |
| FY2013 | Dec 31, 2013 | -215.5% | +812.0 |
| FY2012 | Dec 31, 2012 | -1027.5% | +14080.2 |
| FY2011 | Dec 31, 2011 | -15107.7% | +7592.3 |
| FY2010 | Dec 31, 2010 | -22700.0% | – |
See a number that looks wrong?